Two projects of Arjen Blom and Peter van Lent, theme Inflammatory diseases, were granted by the Dutch Arthritis Association (ReumaNederland) (€ 160,000 per project).
Osteoarthritis is the most prevalent and debilitating joint disease worldwide but no cure has been developed yet. Recent findings show that low grade inflammation within the OA joint contributes to the pathophysiology and clinical symptoms.
Arjen Blom will focus on novel tools for imaging of early cartilage destruction for diagnostic purposes in rheumatic diseases.
Peter van Lent will focus on the therapeutic efficacy of fat derived stem cells in dampening synovitis and development of joint destruction in posttraumatic OA.
Related news items
Cycling the Tour de France for the Radboud Oncology Fund17 January 2019
It's a boy's dream: cycling the Tour de France. Bart Kiemeney, RIHS director and chairman of the Radboud Oncology Fund, wants to do it.read more
A personal touch of Blanca Scheijen17 January 2019
In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t! This week: Blanca Scheijen.read more
LEO Foundation grant for Ellen van den Bogaard and Patrick Zeeuwen17 January 2019
LEO Foundation ‘Open competition grants’ are given to support the best dermatology research projects worldwide that improve the understanding of the underlying medicinal, biological, chemical, or pharmacological mechanisms of dermatological diseases and their symptoms.read more
Jolanda de Vries on Dutch National TV in 'Dokters van Morgen'16 January 2019
On Tuesday 15 January, presenter Antoinette Hertsenberg, interviewed Jolanda de Vries, theme Cancer development and immune defense, for a program on Dutch National TV, called the 'Dokters van Morgen'.read more